BALVERSA 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
BALVERSA 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Commercialized
Register Number
1241841009
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Aug 27, 2024
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1241841009
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
ERDAFITINIBActive
Quantity: 4 mg
Name: ERDAFITINIB
ATC CLASSIFICATION (3)
L01E
L01EN
L01EN01